FOCUS joined other industry experts discuss the current state of M&A in the software and SaaS space. Valuations, the impacts of remote work, creative due diligence tactics and how buyers and sellers are sharing risk to get transactions to the finish line are all covered in this virtual roundtable.
It is no surprise that middle market M&A has not escaped the current economic crisis—as it is filled with companies across a wide array of industries that have been seriously impacted by the country’s abrupt slowdown. However, the effect has not been uniform across industry sectors and the stage in the process. Some sectors continue to press ahead while others have halted altogether. FOCUS Investment Banking has been asked by several partners to provide insight and perspective on the current state and future outlook for middle market M&A given the current market environment. FOCUS gathered the questions and then engaged with its team of over 40 bankers and senior advisors, across its ten industry practices, gathering responses to the questions posed.
Eight years of consolidation activity has resulted in a wide spread of PE-backed practices across the United States.
Based on our detailed tracking and analysis, the dermatology market is only 11.5% consolidated as of this publication.
Two key factors provide a view of current and future consolidation speed.
The number of private equity firms investing in gastroenterology practices and surgery centers doubled in 2019. As of the end of 2019, six PE firms were actively investing in the space with three new firms entering in the last three quarters of 2019.
As of the end of 2019, there were 25 private equity firms actively investing in ophthalmology practices and surgery centers. It is among the most active physician practice consolidations currently taking place in the United States.
Our recently published white paper examined all core aspects of private equity's investment in ophthalmology practices and surgery centers from 2012 – 2019.
Many Physician-owners of specialty medical practices and surgery centers are considering their best "end-game" strategy for the business they have spent a lifetime building.
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC © 2025 FOCUS Investment Banking LLC
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC © 2025 FOCUS Investment Banking LLC
